Table 1.
Preintervention | Postintervention | P values | |
Age (median) | 54 | 54 | Mann-Whitney U test, p=0.133 |
Gender—female | 700/1198 (58.4%) | 696/1135 (61.3%) | Two-proportion test, p=0.154 |
Gender—male | 498/1198 (41.6%) | 439/1135 (38.7%) | Two-proportion test, p=0.154 |
Severity 1—minor | 151/1198 (12.6%) | 207/1135 (18.2%) | χ2, p=0.002, two-proportion test, p<0.001 |
Severity 2—moderate | 451/1198 (37.6%) | 409/1135 (36.0%) | Two-proportion test, p=0.420 |
Severity 3—major | 496/1198 (41.4%) | 422/1135 (37.2%) | Two-proportion test, p=0.037 |
Severity 4—extreme | 100/1198 (8.3%) | 96/1135 (8.5%) | Two-proportion test, p=0.923 |
No severity score listed | 0/1198 (0%) | 1/1135 (0.1%) | Two-proportion test, p=0.317 |
Length of stay (median) | 3 Days (4.4 days average) |
3 Days (4.0 days average) |
Mann-Whitney U test, p=0.003 |
Complications of care | 18/1198 (1.5%) | 6/1135 (0.5%) | Two-proportion test, p=0.018 |
30-Day readmission with exclusions (any APR-DRG)* | 180/1107 (16.3%) | 141/1058 (13.3%) | Two-proportion test, p=0.054 |
Mortality rate with exclusions* | 22/1197 (1.8%) | 19/1132 (1.7%) | Two-proportion test, p=0.770 |
Patient characteristics were measured for the Family Medicine Hospitalist service from the Crimson database 12 months before and after the intervention.
*Crimson 30-day readmission excluded Centers for Medicare and Medicaid Services (CMS) approved readmissions including chemotherapy, radiotherapy, dialysis, rehabilitation, elective admission, patients discharged against medical advice, mortalities, length of stay greater than 1 year and transfers to other acute-care facilities. All severity adjusted All Patient Refined Diagnosis Related Groups (APR-DRGs) were included in the readmission data. Mortality rate excluded cases with uncertainty of how much influence the physician had on the case including chemotherapy and radiotherapy patients, length of stay over 1 year, inpatient transfers from other acute-care facilities and hospice patients according to Crimson guidelines.